Berlin, Germany

Heike Enke

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Heike Enke: Innovator in Cancer Treatment

Introduction: Heike Enke is a notable inventor based in Berlin, Germany, known for his significant contributions to the field of biochemistry and cancer treatment. With a remarkable portfolio of 16 patents, Enke has demonstrated a commitment to advancing medical science through innovative research.

Latest Patents: Among his latest inventions, Enke has developed a compound that includes cytotoxic agents such as microcystin and nodularin, which are crucial for cancer treatment. This compound is characterized by modified microcystins and/or nodularins that contain modified substrates. The innovative design allows for the inclusion of an anchor group, which is directly accessible or transformable for use in conjugation chemistry, including click chemistry, for attaching targeting moieties. Additionally, Enke has patented a method for modifying these compounds, which involves cultivating a modified non-ribosomal peptide-producing cyanobacteria strain and introducing modified substrates, such as amino acids, into the culture. The resulting modified non-ribosomal peptide is promising for the therapy of various diseases.

Career Highlights: Heike Enke has made significant strides in his career, evidenced by his work with leading companies in the biotech sector, including Algenol Biotech LLC and Algenol Biofuels, Inc. His research focuses on enhancing the therapeutic applications of natural compounds for improving patient outcomes in the realm of cancer treatment.

Collaborations: Throughout his career, Enke has collaborated with several esteemed professionals in the field, including Ulf Dühring and Kerstin Baier. These collaborations have helped propel his innovative research forward and have ensured a multidisciplinary approach to tackling complex biological challenges.

Conclusion: Heike Enke stands out as a pioneering inventor whose work in modifying microcystins and nodularins holds great promise for advancing cancer treatment. With his impressive patent portfolio and collaborative efforts, Enke continues to impact the field of biotechnology and cancer research significantly. His contributions are not just advancements in science but also potential solutions for patients battling serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…